These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19129715)

  • 1. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.
    Fofanova-Gambetti OV; Hwa V; Kirsch S; Pihoker C; Chiu HK; Högler W; Cohen LE; Jacobsen C; Derr MA; Rosenfeld RG
    Horm Res; 2009; 71(2):100-10. PubMed ID: 19129715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature.
    Domené HM; Scaglia PA; Jasper HG
    Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia.
    Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A
    J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
    Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
    Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse.
    Domené HM; Bengolea SV; Jasper HG; Boisclair YR
    J Endocrinol Invest; 2005; 28(5 Suppl):43-6. PubMed ID: 16114275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1).
    Hess O; Khayat M; Hwa V; Heath KE; Teitler A; Hritan Y; Allon-Shalev S; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):838-44. PubMed ID: 23488611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid-labile subunit (ALS) deficiency.
    Domené HM; Hwa V; Jasper HG; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):101-13. PubMed ID: 21396577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations.
    Domené HM; Scaglia PA; Lteif A; Mahmud FH; Kirmani S; Frystyk J; Bedecarrás P; Gutiérrez M; Jasper HG
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4444-50. PubMed ID: 17726072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Homozygous Mutation of the Acid-Labile Subunit
    Poyrazoğlu Ş; Hwa V; Baş F; Dauber A; Rosenfeld R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):432-438. PubMed ID: 30717585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system.
    Domené HM; Scaglia PA; Martínez AS; Keselman AC; Karabatas LM; Pipman VR; Bengolea SV; Guida MC; Ropelato MG; Ballerini MG; Lescano EM; Blanco MA; Heinrich JJ; Rey RA; Jasper HG
    Horm Res Paediatr; 2013; 80(6):413-23. PubMed ID: 24335034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
    Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
    Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel
    Işık E; Haliloglu B; van Doorn J; Demirbilek H; Scheltinga SA; Losekoot M; Wit JM
    Eur J Endocrinol; 2017 Jun; 176(6):657-667. PubMed ID: 28249955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration.
    Grandone A; Miraglia del Giudice E; Cirillo G; Abbondanza C; Cioffi M; Romano T; Micillo F; Marzuillo P; Perrone L
    Horm Res Paediatr; 2014; 81(1):67-72. PubMed ID: 24356109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function.
    Rensing KL; van Duyvenvoorde HA; Cramer MJ; Teske AJ; Prokop M; Stroes ES; Wit JM; Hermus AR; Twickler TB
    Growth Horm IGF Res; 2011 Aug; 21(4):233-7. PubMed ID: 21664162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
    Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure.
    Hwa V; Haeusler G; Pratt KL; Little BM; Frisch H; Koller D; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 May; 91(5):1826-31. PubMed ID: 16507628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.
    van Duyvenvoorde HA; Kempers MJ; Twickler TB; van Doorn J; Gerver WJ; Noordam C; Losekoot M; Karperien M; Wit JM; Hermus AR
    Eur J Endocrinol; 2008 Aug; 159(2):113-20. PubMed ID: 18463107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency.
    Scaglia PA; Keselman AC; Braslavsky D; Martucci LC; Karabatas LM; Domené S; Gutiérrez ML; Ballerini MG; Ropelato MG; Spinola-Castro A; Siviero-Miachon AA; Tartuci JS; Rodríguez Azrak MS; Rey RA; Jasper HG; Bergadá I; Domené HM
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):300-311. PubMed ID: 28445628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: results from the international acid-labile subunit consortium.
    Fofanova-Gambetti OV; Hwa V; Wit JM; Domene HM; Argente J; Bang P; Högler W; Kirsch S; Pihoker C; Chiu HK; Cohen L; Jacobsen C; Jasper HG; Haeusler G; Campos-Barros A; Gallego-Gómez E; Gracia-Bouthelier R; van Duyvenvoorde HA; Pozo J; Rosenfeld RG
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4184-91. PubMed ID: 20591980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IGF system in childhood: physiology and clinical implications.
    Pozo J; Martos-Moreno GA; Barrios V; Argente J
    J Endocrinol Invest; 2005; 28(5 Suppl):38-42. PubMed ID: 16114274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.